Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00030511 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
A Phase 2 study, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00030511 is a Phase 2 study that was terminated before completion, run by European Organisation for Research and Treatment of Cancer - EORTC.
The verdict
NCT00030511, a Phase 2 study, was terminated before completion, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase II trial to study the effectiveness of combining radiation therapy with fluorouracil before surgery in treating patients who have primary or recurrent bile duct cancer.
Interventions
- DRUG fluorouracil
- PROCEDURE conventional surgery
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00030511
The ClinicalTrials.gov registry entry for NCT00030511 describes a study currently listed as terminated, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is European Organisation for Research and Treatment of Cancer - EORTC, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fluorouracil is the first listed.
NCT00030511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00030511 about?
NCT00030511 is a clinical study titled "Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy before surgery may shrink the tumor so that it can be removed during ...
What is the current status of trial NCT00030511?
This trial is currently terminated. It is a Phase 2 study. The study started on 2001-10.
What interventions are being tested in trial NCT00030511?
The interventions under investigation include: fluorouracil (DRUG), conventional surgery (PROCEDURE), radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00030511?
This trial is sponsored by European Organisation for Research and Treatment of Cancer - EORTC, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.